CBD, Genetics, Rare Epilepsies
New epilepsy research on CBD, a new genetic study, TSC, and more.
Genetics, Rare Epilepsies
Validated multiple differentially expressed genes (DEGs), such as glycine receptor subunit 2 and cholecystokinin, at the transcript and/or protein levels, supporting the relevance of these genes to CDKL5-regulated excitability.
Rare Epilepsies
See the impact we have had over the past 25 years, watch UNITE recordings, get ready for Hamilton Unplugged and a Hamilton raffle!
Here, we describe therapeutic strategies for modulating disease-associated RNA molecules and highlight the potential of RNA therapeutics for the treatment of different patient populations such as sporadic, drug-resistant epilepsy, and childhood monogenic epilepsies.
Mechanisms
Featuring the work of CURE Epilepsy’s PTE Initiative Massachusetts General Team. Delineate strategies developed to mitigate the substantial motion artifact that complicates high resolution imaging in large animals, including heartbeat-triggered high-speed image stack acquisition.
CBD
“The medical cannabis research originated from the patient families and advocates in Colorado who have witnessed the positive effects of medical cannabis products.”
Tech/AI
The electrodes allowed doctors to find epilepsy networks in nearly 88 percent of patients.
In 11 participants given the highest dose of 50 mg, increases in EEG spectral power were observed across all bands and distributed over all cortical brain regions.
Genetics
The researchers identified 26 distinct areas in our DNA that appear to be involved in epilepsy. This included 19 which are specific to a particular form of epilepsy called 'genetic generalized epilepsy' (GGE).
